Full-Time

Physician – Obesity Medicine

Posted on 9/19/2025

Mochi Health

Mochi Health

Telehealth obesity treatment with FDA meds

No salary listed

Remote in USA

Remote

Company headquarters in San Francisco, CA; in-person policy for office-based roles; remote role designation 'LI-Remote'.

Category
Medical, Clinical & Veterinary (5)
, , , ,
Requirements
  • MD/DO currently board certified in a speciality recognized by the American Board of Medical Specialties
  • Minimum 2 years post-residency experience in adult primary or specialty care
  • Telemedicine experience preferred
  • Familiarity with or interest in obesity medicine and emerging treatment areas (dermatology, HRT, mental health, hair loss) is a plus
Responsibilities
  • Conduct virtual visits for adults with acute, chronic, and complex medical conditions
  • Provide ongoing obesity and metabolic health management, including GLP-1s and related treatments
  • Deliver patient care in expanding domains such as dermatology, hormone replacement therapy, depression and anxiety, and hair loss management
  • Work closely with Mochi’s multidisciplinary care team to coordinate patient care
  • Use cost-conscious prescribing practices, offering compounded and generic options when appropriate
  • Participate in continuing education through our optional monthly academic lecture series
Desired Qualifications
  • Board-certified physicians in specialties recognized by ABMS
  • Experience with virtual care platforms or telemedicine
  • Interest or experience in obesity medicine and related areas like dermatology, HRT, mental health, and hair loss

Mochi Health provides telehealth obesity treatment with personalized care using FDA-approved medications. Patients join a subscription that includes medical consultations and prescribed therapies, with options for cost-effective compounded generics. It focuses on underserved groups such as the uninsured, people facing language or cultural barriers, and residents of rural areas to remove access barriers in care. The goal is to make effective obesity treatment accessible and affordable by bundling ongoing care with affordable medication options.

Company Size

N/A

Company Stage

Seed

Total Funding

$550K

Headquarters

San Francisco, California

Founded

2022

Simplify Jobs

Simplify's Take

What believers are saying

  • Insurance-based plans launched May 2025 expand access with dietitians.
  • Wegovy pill provides FDA-approved oral obesity treatment option.
  • Compounded semaglutide offers affordable appetite-curbing alternative.

What critics are saying

  • Eli Lilly sues Mochi for deceptive tirzepatide marketing in 2026.
  • Novo Nordisk litigates Mochi over compounded semaglutide adverse events.
  • FDA probes Mochi-affiliated pharmacies for contamination and violations.

What makes Mochi Health unique

  • Mochi Health offers pediatric obesity programs at $99/mo for family care.
  • Dynamic protocols include 100+ nutritionist meal plans and sleep content.
  • Unlimited 24/7 messaging enables rapid treatment plan adjustments.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mochi Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Unlimited Paid Time Off

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Commuter Benefits

Company News

HIT Consultant
May 27th, 2025
Mochi Health Launches Insurance-Based Plans, Expanding Access To Personalized Obesity Care With Behavioral Therapy

Mochi Health Launches Insurance-Based Plans, Expanding Access to Personalized Obesity Care with Behavioral Therapy. by Jasmine Pennic 05/27/2025 Leave a Comment. What You Should Know: – Mochi Health, a physician-guided obesity care program, announced the launch of its new insurance-based plans. – These expanded offerings are designed to provide more personalized treatment experiences for patients, placing a strong emphasis on comprehensive obesity care that spans all aspects of an individual’s health. – The new insurance-based plans are available as an optional upgrade to Mochi’s existing offerings. They provide patients with access to either brand-name or compounded weight loss medication prescriptions, alongside routine video consultations with both a physician and a registered dietitian.Addressing a Growing National Health ConcernThe launch comes at a time when nearly three-quarters of U.S. adults are classified as overweight or obese, and approximately one in eight Americans are reportedly using GLP-1 medications for weight loss, underscoring the significant demand for effective solutions. Mochi Health’s expanded offerings aim to meet this need by blending personalized care with comprehensive support, recognizing that effective treatment must be tailored to the individual.Expanding Access to Comprehensive, Personalized Weight Loss SolutionsMochi Health’s new plans aim to cater to the unique needs of each individual navigating their weight loss journey

GlobalData
Apr 23rd, 2025
Eli Lilly sues Mochi Health and others for 'deceptive' tirzepatide marketing

Eli Lilly sues Mochi Health and others for 'deceptive' tirzepatide marketing.

INACTIVE